# Mini-Dose Glucagon to Treat Non-Severe Hypoglycemia

> **NCT02411578** · PHASE2 · COMPLETED · sponsor: **Jaeb Center for Health Research** · enrollment: 26 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** G-Pen Mini™ (glucagon injection)
- **OTHER:** Glucose Tablets

## Key facts

- **NCT ID:** NCT02411578
- **Lead sponsor:** Jaeb Center for Health Research
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2016-04
- **Final completion:** 2016-05
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2020-03-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02411578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02411578, "Mini-Dose Glucagon to Treat Non-Severe Hypoglycemia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02411578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*